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Thalassemia is common inherited disorder among humans, and they represent a major public health problem in many areas of the world. The study 
aimed to the measurement of hematological characterization of beta-thalassemia in Sudanese patients. Blood samples from 61 beta-thalassemic 
patients were collected after written consent form obtained from all participants. The frequency of adults (>18 years) was 45 (73.8%) and children’s 
(<18 years) was 16 (26.2%); the frequency of male was 27 (44.3%) and 34 were female (55.7%). Hemoglobin estimation and red cell indices were 
carried out using the automatic blood cell counter Sysmex K × 21N. The results showed that Hb and RBCs indices were varied between mild to 
moderate and severe decreasing, hemoglobin concentration (Hb) with the mean value of 9.6 g/dL, with minimum value of 6.1 g/dl and maximum 
of 11.9 g/dl, while RBCs were increased in all patients, mean value 5.2 c/l, mean corpuscular volume mean was 58.9 fl, hematocrit was 30.4, mean 
corpuscular hemoglobin (MCH) 18.8 pg, mean corpuscular hemoglobin concentration (MCHC) was 31.7pg, and RDW was 18.8%. The method used for 
hemoglobin electrophoresis was capillary electrophoresis, Hb pattern shows increased HbA2 and HbF, the mean of HbA is 78.3%, HbF is 2.3%, and 
HbA2 is 6.5% with the min. value of 3.6% and max. of 12.2%. While the mean of serum iron was 82.75 µg/dl, 7 patients showed low level, 19 high level, 
and 35 were normal level. Comparison of hematological analysis (HbA2) in thalassemic patients coexisted with iron deficiency and without result was 
insignificant difference (p=0.645), this result disagrees with references that say iron deficiency masking HbA2. Nevertheless, the association between 
HbA2 and HbF revealed a statistically significant difference (p<0.013) and HbA2 with Hb was insignificant (p=0.260).
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INTRODUCTION diagnosis. In thalassemia trait, MCV and MCH are low while MCHC 
is marginally reduced or normal. Hemoglobin electrophoresis and 
molecular study are essential for definite diagnosis of β-thalassemia 
cases. Normally Hb A2 is <3.2%, but in βeta-thalassemia trait, it is more 
than 3.5% [1].
MATERIALS AND METHODS
A cross-sectional descriptive study was carried out to detect 
hematological characterization of beta-thalassemia Sudanese patient in 
Khartoum State, Sudan, during the period of July 2017–July 2019. From 
each patient, 2.5 ml of venous blood sample was collected in sterile 
EDTA container. The blood samples were analyzed for complete blood 
count (CBC) using the automated hematology analyzer Sysmex K × 21N 
(manufactured by Sysmex corporation Kobe, Japan) within 24 h of blood 
collection. On the same day itself, the blood samples were screened for 
hemoglobinopathies by Hb electrophoresis method (Sebia, France). 
The inclusion criteria patients were diagnosed as beta-thalassemia, 
availability of patient demographic data, and laboratory reports (CBC, 
hemoglobin electrophoresis, and peripheral blood picture, and iron 
studies). Patients not diagnosed as beta-thalassemia or coexisted with 
other hemoglobin variants or with other hematological malignancy 
excluded from the study. Permission of this study was obtained from 
the local authorities in the area of the study. The objective of the study 
explained to all individuals participating in this study. An informed 
written consent obtained from all participants.
RESULTS
Out of 61 beta-thalassemic patients, the frequency of adults (>18 years) 
was 45 (73.8%) and 16 (26.2%) was children (18 years), and the 
frequency of male to female was 27 of the patients were male (44.3%) 
and 34 were female (55.7%), as shown in Table 1. Hemoglobin 
estimation and red cell indices were carried out using the automatic 
blood cell counter Sysmex K × 21N. The results obtained were as 
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ABSTRACT
Thalassemia is a Mendelian autosomal recessive heritable blood 
disorder, it is a group of genetically determined microcytic, 
hypochromic anemia’s resulting from a decrease in synthesis of one or 
more globin chains in the hemoglobin molecule [4]. The most common 
types are alpha- and beta-thalassemia according to which globin 
chain is reduced [15]. Beta-thalassemia is classified into three types 
depending on the severity of symptoms: Thalassemia major also known 
as  Cooley’s  anemia [8,16].  Thalassemia  intermediate  and thalassemia 
minor, thalassemia major is more severe. The signs and symptoms of 
thalassemia major appear within the first 2 years of life, children develop 
life-threatening anemia, and they do not gain weight and grow at the 
expected rate (failure to thrive) and may develop yellowing of the skin 
and whites of the eyes (jaundice) [18]. Affected individuals may have an 
enlarged spleen, liver, heart, and their bones which may be misshapen. 
Some adolescents with thalassemia major experience delayed puberty. 
Many people with thalassemia major have such severe symptoms that 
they need frequent blood transfusions to replenish their red blood cell 
supply overtime, an influx of iron-containing hemoglobin from chronic 
blood transfusions can lead to a buildup of iron in the body, resulting in 
liver,  heart,  and hormone problems.  Thalassemia intermedia is  milder 
than thalassemia major (Yaish et al.,  2009). The signs and symptoms 
of thalassemia intermedia appear in early childhood or later in life. 
Affected individuals have mild-to-moderate anemia and may also have 
slow growth and bone abnormalities (Raffaella, 2015; GHR, 2002). 
The disorder may occur in the homozygous or heterozygous state. 
Heterozygotes may be asymptomatic,  but homozygotes typically have a 
severe, often fatal, disease. It involves increased (HbA2) and decreased 
production of normal adult hemoglobin (Hb A), the predominant type 
of hemoglobin from soon after birth until death [6]. Mostly, the patients 
are diagnosed on routine blood examination. Beta-thalassemia carrier, it
 is  commonly  not  diagnosed  until  adolescence  or  adult  life  and  may  be 
detected in a routine hematological screening examination. The red cell 
indices, Hb electrophoresis, and molecular studies give more reliable 
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follows: Hemoglobin concentration (Hb) with the mean value of 
9.6 g/dL, with minimum value of 6.1 g/dl, and maximum of 11.9g/dl, 
while RBCs were increased in all patients with mean value of 5.2 c/l, 
mean corpuscular volume (MCV) mean was 58.9 fl, hematocrit was 
30.4, mean corpuscular hemoglobin (MCH) 18.8 pg, mean corpuscular 
hemoglobin concentration (MCHC) was 31.7 pg, and RDW was 18.8%, 
as shown in Table 2. The method used for hemoglobin electrophoresis 
was capillary electrophoresis; the Hb pattern shows increased HbA2 
and HbF, the mean of HbA is 78.3%, HbF is 2.3%, and HbA2 is 6.5% 
with the min. value of 3.6% and max. of 12.2%, as shown in Table 3. 
The mean of serum iron was 82.75 µg/dl, 7 patients showed low level, 








Fig. 1: Frequency of iron level in the study group
Table 2: Mean and standard deviation of Hb and RBC indices in the study group
Parameters Hb/g/d HCT RBCs MCV MCH/pg MCHC/pg RDW%
Mean 9.618 30.364 5.197 58.882 18.761 31.657 18.825
Std. deviation 1.3214 3.6247 .7394 6.5545 2.9306 1.7615 2.9644
Minimum 6.1 18.8 3.2 44.2 13.3 27.2 12.5
Maximum 11.9 36.2 6.7 76.4 27.2 35.6 23.3
Fig. 2: Hb A2 in thalassemic patients coexisted with iron deficiency
Table 1: Gender and age distribution in the study group
Frequency Percentage
For 61 beta-thalassemic patients, hemoglobin estimation and red 
cell indices were carried out using the automatic blood cell counter 
Sysmex KX21N. The results obtained were; overall mean hemoglobin 
concentration (Hb) was decreased 9.6 g/dl. Red blood cell count 
(RBC) 5.19 × 1012 cell/L was found to be raised. Red blood cell indices 
were found to be low (packed cell volume mean cell volume (MCV) 
58.9 fl, mean cell hemoglobin (MCH) 18.8 pg, mean cell hemoglobin 
concentration (MCHC) 31.7 g/dl, red cell distribution width (RDW) 
18.8); these results agreed with several studies in the literature, for 
example ([9], Tahir et al., Idit et al.), specially with Dr. Sana, 2013, 
literature. Furthermore, this study agreed with the data mentioned 
in Thalassemia International Federation. Hb electrophoresis was 
measured by capillary electrophoresis results shows mean of HbF is 
2.3% which was high, and HbA2 is 6.5% with the min value of 3.6% and 
max of 12.2% also shows significant increase which agreed with several 
studies e.g., ([5]; Mohammed et al., 2014). The mean of serum iron was 
82.75 µg/dl, 7 patients showed low level, 35 were normal level, and 
19 high levels those are mainly due to blood transfusion; unfortunately, 
data of blood transfusion were missing in this study. Many studies 
show similar result unless in recurrent transfused thalassemic patient 
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levels are much higher. Comparison of hematological analysis (HbA2) in 
thalassemic patients coexisted with iron deficiency and without result 
was insignificant difference (p=0.645); this result disagrees with many 
references that say iron deficiency masking HbA2. Nevertheless, the 
association between HbA2 and HbF revealed a statistically significant 
difference (p<0.013), that means, there is positive correlation between 
HbA2 and Hb F and the correlation between HbA2 with Hb was 
insignificant (p=0.260).
CONCLUSION
This study was detected the hematological characterization of 
beta-thalassemia; the results obtained for Hb, RBC indices, and Hb 
electrophoresis were agreed with several studies. In areas where 
modern equipment’s for diagnosis are not available, the red cell indices 
and hemoglobin electrophoresis give more reliable diagnosis for beta-
thalassemia and molecular study provides definitive diagnosis. Since 
there are no symptoms for beta-thalassemia trait, it is very important to 
discover at early as possible from routine hematological test to prevent 
beta-thalassemia major offspring’s.
ACKNOWLEDGMENTS
The authors are grateful to staff of pediatric teaching hospital for 
helping in sample collection. Special thanks to my family for their 
support, encouragement, and patient.
CONFLICTS OF INTEREST
Authors declare that no conflicts of interest exist in this paper.
1. Firkin F, Chesterman C, Penington D, Rush B. De Gruchy’s Clinical 
Haematology in Medical Practice. 5th ed. London: Blackwell Publishing; 
1989.
2. Thalassaemia International Federation. Guidelines to the Clinical 
Management of Thalassemia. (World Bank 2006, Report of a Joint 
WHO-March of Dime Meeting 2006). San Francisco: Thalassaemia 
International Federation; 2000.
3. Eleftheriou A, Angastiniotis M. Hematological Indices Most 
Commonly Found in Patients with Thalassemia, Hemoglobinopathesis 
B-Thalassemia Booklet, 1986, Report of a Joint WHO. Nicosia: 
Thalassemia International Federation; 1996.
4. Hoffbrand AV, Catovsky D, Edward GD. Postgraduate Haematology. 
5th ed., Vol. 1. United Kingdom: Blackwell Publishing; 2005. p. 85-103.
5. Sana E. Molecular Genetics of Beta Thalassaemia in Sudan. 
United Kingdom: Lambert Academic Publishing; 2013.
Haematol 2008;141:357-66.
8. Cooley TB. Disorders of the blood. In: Brennemann’s Practice of 
Pediatrics. Hagerstown, MD: W.F. Prior Company Inc.; 1945.
9. Galanello R, Melis MA, Ruggeri R, Addis M, Scalas MT, Maccioni L, 
et al. Beta 0 thalassemia trait in Sardinia. Hemoglobin 1979;3:33-46.
10. Jameel T, Baig M, Ahmed L, Hussain MB, Alkhamaly M. Differentiation 
of beta thalassemia trait from iron deficiency anemia by hematological 
indices. Pak J Med Sci 2017;33:665-9.
11. Roth IL, Lachover B, Koren G, Levin C, Zalman L, Koren A. Detection 
of β-thalassemia carriers by red cell parameters obtained from automatic 
counters using mathematical formulas. Mediterr J Hematol Infect Dis 
2018;10:e2018008.
12. Abbas MY. Haematological parameters in Sudanese children with 
sickle cell disease. Am J Res Commun 2014;2:20-32.
13. Gireel MO, Elkarsani M, Munsour MM, El Taher HB. A screening of 
hemoglobinopathy in Bija tribes and other minor groups living in Port 
Sudan. J Med Lab Diagn 2014;5:35-40.
14. Origa R. Beta-thalassemia. In: Gene Reviews. Seattle, WA: University 
of Washington; 2018.
15. Weatherall DJ. Genetic disorder of hemoglobin. In: Postgraduate 
Haematology. 5th ed. 1999. p. 91-119.
16. Whipple CH, Bradford WL. Mediterranean disease-thalassemia 
(erythroblastic anemia of cooley); associated pigment abnormalities 
stimulating hemochromatosis. J Pediatric 1936;9:279-31.
17. Yaish HM, Arceci RJ. Pediatric Thalassemia. Vol. 9. Sunnyvale, CA: 
Intermedia.Net, Inc.; 2009. p. 29.
18. Piomelli S, Loew T. Management of thalassemia major. Hematol Oncol 
Clin North Am 1999;5:557-69.
Table 3: Hb electrophoresis pattern in thalassemic patients
Hb electrophoresis parameters HbA2/% HbF/% HbA/%
Minimum 3.6 0.4 70.1
Maximum 12.2 10.4 92.7
Mean 6.498 2.277 78.289
Std. deviation 1.3895 1.9511 3.2221




Fig. 3: Hb A2 in normal iron group
Iron result
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